Syndrome of inappropriate antidiuresis

References

• Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am. J. Med.23(4), 529–542 (1957).
   PubMed Web of Science ®Google Scholar
• Zerbe R, Stropes L, Robertson G. Vasopressin function in the syndrome of inappropriate antidiuresis. Ann. Rev. Med.31, 315–327 (1980).
   PubMed Web of Science ®Google Scholar
• Verbalis JG. Disorders of body water homeostasis. Best Prac. Res. Clin. Endocrinol. Metab.17(4), 471–503 (2003).
   PubMed Web of Science ®Google Scholar
• Milionis HJ, Liamis GL, Elisaf MS. The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ.166(8), 1056–1062 (2002).
   PubMed Web of Science ®Google Scholar
• Smith D, McKenna K, Thompson CJ. Hyponatremia. Clin. Endocrinol.52, 667–678 (2000).
   PubMedGoogle Scholar
• Yeates KE, Singer M, Morton AR. Salt and water: a simple approach to hyponatremia. CMAJ.170(3), 365–369 (2004).
   PubMedGoogle Scholar
• Zimmerman EA, Ma LY, Nilaver G. Anatomical basis of thirst and vasopressin secretion. Kidney Int. Suppl.21, S14–S19 (1987).
   Google Scholar
• Thrasher TN, Keil LC. Regulation of drinking and vasopressin secretion: role of organum vasculosum laminae terminalis. Am. J. Physiol.253(1 Pt 2), R108–R120 (1987).
   PubMedGoogle Scholar
• McKinley MJ, Mathai ML, McAllen RM et al. Vasopressin secretion: osmotic and hormonal regulation by the lamina terminalis. J. Neuroendocrinol.16(4), 340–347 (2004).
   PubMed Web of Science ®Google Scholar
• Hammond DN, Moll GW, Robertson GL, Chelmicka-Schorr E. Hypodipsic hypernatremia with normal osmoregulation of vasopressin. N. Engl. J. Med.315(7), 433–436 (1986).
   PubMed Web of Science ®Google Scholar
• Robertson GL, Aycinena P, Zerbe RL. Neurogenic disorders of osmoregulation. Am. J. Med.72(2), 339–353 (1982).
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Bland J, Burd J et al. The osmotic thresholds for thirst and vasopressin release are similar in healthy man. Clin. Sci.71(6), 651–656 (1986).
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Burd JM, Baylis PH. Acute suppression of plasma vasopressin and thirst after drinking in hypernatraemic humans. Am. J. Physiol.252, 1138–1142 (1987).
   PubMed Web of Science ®Google Scholar
• Thompson CJ, Selby P, Baylis PH. Reproducibility of osmotic and nonosmotic tests of vasopressin secretion in men. Am. J. Physiol.260(3 Pt 2), R533–R539 (1991).
   Google Scholar
• Phillips PA, Rolls BJ, Ledingham JG et al. Reduced thirst after water deprivation in healthy elderly men. N. Engl. J. Med.311(12), 753–759 (1984).
   PubMed Web of Science ®Google Scholar
• Ishikawa SE, Schrier RW. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion.Clin. Endocrinol.58(1), 1–17 (2003).
   PubMed Web of Science ®Google Scholar
• Schrier RW, Chen Y-C, Cadnapaphornchai MA. From finch to fish to man: Role of aquaporins in body fluid and brain water regulation. Neuroscience129(4), 897–904 (2004).
   PubMed Web of Science ®Google Scholar
• Seute T, Leffers P, ten Velde GP, Twijnstra A. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer100(4), 801–806 (2004).
   PubMed Web of Science ®Google Scholar
• Agha A, Thornton E, O’Kelly P et al. Posterior pituitary dysfunction after traumatic brain injury. J. Clin. Endocrinol. Metab.89(12), 5987–5992 (2004).
   PubMed Web of Science ®Google Scholar
• Agha A, Rogers B, Mylotte D et al. Neuroendocrine dysfunction in the acute phase of traumatic brain injury. Clin. Endocrinol.60(5), 584–591 (2004).
   PubMed Web of Science ®Google Scholar
• Agha A, Sherlock M, Philips J, Tormey W, Thompson CJ. The natural history of post-traumatic neurohypophysial dysfunction. Eur. J. Endocrinol.152, 371–377 (2005).
   PubMed Web of Science ®Google Scholar
• Sherlock M, O’Sullivan E, Agha A et al. The incidence and pathophysiology of hyponatremia after subarachnoid haemorrhage. Clin. Endocrinol.64(3), 250–254 (2006).
   PubMed Web of Science ®Google Scholar
• Matsumoto H. Hyponatremia associated with selective serotonin reuptake inhibitors. Intern. Med.44(3), 173–174 (2005).
   PubMedGoogle Scholar
• Miehle K, Paschke R, Koch CA. Citalopram therapy as a risk factor for symptomatic hyponatremia caused by the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): a case report. Pharmacopsychiatry38(4), 181–182 (2005).
   PubMedGoogle Scholar
• Bouman WP, Pinner G, Johnson H. Incidence of selective serotonin reuptake inhibitor induced hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion in the elderly. Int. J. Geriatr. Psych.13, 123–125 (1998).
   Google Scholar
• Budisavljevic MN, Stewart L, Sahn SA et al. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse. Am. J. Med. Sci.326(2), 89–93 (2003).
   PubMed Web of Science ®Google Scholar
• Hew-Butler T, Almond C, Ayus JC et al. Consenus statement of the 1st International Exercise-associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clin. J. Sport Med.15(4), 208–213 (2005).
   PubMed Web of Science ®Google Scholar
• Almond CSD, Shin AY, Fortescue EB et al. Hyponatremia among runners in the Boston marathon. N. Engl. J. Med.15, 1550–1556 (2005).
   Google Scholar
• George JM, Capen CC, Philips AS. Biosynthesis of vasopressin in vitro and ultrastructure of a bronchogenic cancer. J. Clin. Invest.51, 141–148 (1972).
   PubMedGoogle Scholar
• Gross AJ, Steinberg SM, Reilly JG et al. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res.53(1), 67–74 (1993).
   PubMed Web of Science ®Google Scholar
• Smith D, Moore K, Tormey W et al. Downward resetting of the osmotic threshold for thirst in patients with SIADH. Am. J. Physiol. Endocrinol. Metab.287(5), E1019–E1023 (2004).
   PubMed Web of Science ®Google Scholar
• Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int. J. Biochem. Cell Biol.35(11), 1495–1499 (2003).
   PubMed Web of Science ®Google Scholar
• Feldman BJ, Rosenthal SM, Vargas GA et al. Nephrogenic syndrome of inappropriate antidiuresis. NEJM352(18), 1884–1890 (2005).
   PubMed Web of Science ®Google Scholar
• Ishikawa S, Saito T, Kasono K. Pathological role of aquaporin-2 in impaired water excretion and hyponatremia. J. Neuroendocrinol.16(4), 293–296 (2004).
   PubMedGoogle Scholar
• Saito T, Higashiyama M, Nagasaka S, Sasaki S, Saito T, Ishikawa SE. Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis. Kidney Int.60(4), 1266–1276 (2001).
   PubMedGoogle Scholar
• Kamoi K, Ebe T, Kobayashi O et al. Atrial natriuretic peptide in patients with the syndrome of inappropriate antidiuretic hormone secretion and with diabetes insipidus. J. Clin. Endocrinol. Metab.70(5), 1385–1390 (1990).
   PubMed Web of Science ®Google Scholar
• Verbalis JG, Murase T, Ecelbarger CA, Nielsen S, Knepper MA. Studies of renal aquaporin-2 expression during renal escape from vasopressin-induced antidiuresis. Adv. Exp. Med. Biol.449, 395–406 (1998).
   PubMedGoogle Scholar
• Levinsky NG, Davidson DG, Berliner RW. Changes in urine concentration during prolonged administration of vasopressin and water. Am. J. Physiol.196(2), 451–456 (1959).
   PubMedGoogle Scholar
• Verbalis JG. Escape from vasopressin-induced antidiuresis: insights at the molecular level. News Physiol. Sci.14, 221 (1999).
   PubMedGoogle Scholar
• Verbalis JG. Escape from antidiuresis: a good story. Kidney Int.60(4), 1608–1610 (2001).
   PubMedGoogle Scholar
• Ecelbarger CA, Nielsen S, Olson BR et al. Role of renal aquaporins in escape from vasopressin-induced antidiuresis in rat. J. Clin. Invest.99(8), 1852–1863 (1997).
   PubMedGoogle Scholar
• Tian Y, Sandberg K, Murase T, Baker EA, Speth RC, Verbalis JG. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced antidiuresis. Endocrinology141(1), 307–314 (2000).
   PubMedGoogle Scholar
• Ecelbarger CA, Chou CL, Lee AJ, DiGiovanni SR, Verbalis JG, Knepper MA. Escape from vasopressin-induced antidiuresis: role of vasopressin resistance of the collecting duct. Am. J. Physiol.274(6 Pt 2), F1161–F1166 (1998).
   Google Scholar
• Ecelbarger CA, Knepper MA, Verbalis JG. Increased abundance of distal sodium transporters in rat kidney during vasopressin escape.J. Am. Soc. Nephrol.12(2), 207–217 (2001).
   PubMedGoogle Scholar
• Song J, Xinqun H, Khan O, Tian Y, Verbalis JG, Ecelbarger CA. Increased blood pressure, aldosterone activity and regional differences in renal EnaC protein during vasopressin escape. Am. J. Physiol. Renal Physiol.287, F1076–F1083 (2004).
   Google Scholar
• Anderson RJ. Hospital-associated hyponatremia. Kidney Int.29(6), 1237–1247 (1986).
   PubMed Web of Science ®Google Scholar
• Saeed BO, Beaumont D, Handley GH, Weaver JU. Severe hyponatremia: investigation and management in a district general hospital. J. Clin. Pathol.55(12), 893–896 (2002).
   PubMed Web of Science ®Google Scholar
• Diederich S, Franzen NF, Bahr V, Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur. J. Endocrinol.148(6), 609–617 (2003).
   PubMed Web of Science ®Google Scholar
• Chen YC, Cadnapaphornchai MA, Summer SN et al. Molecular mechanisms of impaired urinary concentrating ability in glucocorticoid-deficient rats. J. Am. Soc. Nephrol.16(10), 2864–2871 (2005).
   PubMedGoogle Scholar
• Olchovsky D, Ezra D, Vered I, Hadani M, Shimon I. Symptomatic hyponatremia as a presenting sign of hypothalamic-pituitary disease: a syndrome of inappropriate secretion of antidiuretic hormone (SIADH)-like glucocorticosteroid responsive condition.J. Endocrinol. Invest.28(2), 151–156 (2005).
   PubMedGoogle Scholar
• Saito T, Ishikawa SE, Ando F, Higashiyama M, Nagasaka S, Sasaki S. Vasopressin-dependent upregulation of aquaporin-2 gene expression in glucocorticoid-deficient rats. Am. J. Physiol. Renal Physiol.279(3), F502–F508 (2000).
   PubMed Web of Science ®Google Scholar
• Okada K, Nomura M, Furusuyo N, Otaguro S, Nabeshima S, Hayashi J. Amelioration of extrapontine myelinolysis and reversible parkinsonism in a patient with asymptomatic hypopituitarism. Intern. Med.44(7), 739–742 (2005).
   PubMedGoogle Scholar
• Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N. Engl. J. Med.321, 492–496 (1989).
   PubMedGoogle Scholar
• Fox J, Falik JL, Shalboub RJ. Neurosurgical hyponatremia: the role of inappropriate antidiuresis. J. Neurosurg.34, 506–514 (1971).
   PubMed Web of Science ®Google Scholar
• Agha A, Rogers B, Sherlock M et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J. Clin. Endocrinol. Metab.89(10), 4929–4936 (2004).
   PubMed Web of Science ®Google Scholar
• Aimaretti G, Ambrosio MR, Di Somma C et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin. Endocrinol. (Oxf).61(3), 320–326 (2004).
   PubMed Web of Science ®Google Scholar
• Agha A, Sherlock M, Thompson CJ. Post-traumatic hyponatremia due to acute hypopituitarism. QJM98(6), 463–464 (2005).
   PubMed Web of Science ®Google Scholar
• Sari R, Sevinc A. Life-threatening hyponatremia due to cessation of l-thyroxine. J. Natl. Med. Assoc.95(10), 991–994 (2003).
   PubMedGoogle Scholar
• Taskapan C, Sahin I, Taskapan H, Kaya B, Kosar F. Possible malignant neuroleptic syndrome that associated with hypothyroidism. Prog. Neuropsychopharmacol. Biol. Psych.29(5), 745–748 (2005).
   PubMedGoogle Scholar
• Chen YC, Cadnapaphornchai MA, Yang J et al. Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am. J. Physiol. Renal Physiol.289(4), F672–F678 (2005).
   Google Scholar
• Hanna FW, Scanlon MF. Hyponatremia, hypothyroidism and role of arginine-vasopressin. Lancet350, 755–756 (1997).
   PubMedGoogle Scholar
• Schmitz PH, de Meijer PH, Meinders AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth. J. Med.58(3), 143–149 (2001).
   PubMedGoogle Scholar
• Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I. Changes in renal function in primary hypothyroidism. Am. J. Kidney Dis.27(2), 195–198 (1996).
   PubMed Web of Science ®Google Scholar
• Peters JP, Welt LG, Sims EA et al. A salt-wasting syndrome associated with cerebral disease. Trans. Assoc. Am. Phys.63, 57–64 (1950).
   PubMedGoogle Scholar
• Wijdicks EF, Vermeulen M, Hijdra A, vanGijn J. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful? Ann. Neurol.17(2), 137–140 (1985).
   PubMed Web of Science ®Google Scholar
• Sivakumar V, Rajshekhar V, Chandy MJ. Management of neurosurgical patients with hyponatremia and natriuresis. Neurosurgery34(2), 269–274 (1994).
   PubMed Web of Science ®Google Scholar
• Oh MS, Carroll HJ. Cerebral salt-wasting syndrome. We need better proof of its existence. Nephron82(2), 110–114 (1999).
   PubMed Web of Science ®Google Scholar
• Singh S, Bohn D, Carlotti AP, Cusimano M, Rutka JT, Halperin ML. Cerebral salt wasting: truths, fallacies, theories, and challenges. Crit. Care Med.30(11), 2575–2579 (2002).
   PubMedGoogle Scholar
• Berendes E, Walter M, Cullen P et al. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet349(9047), 245–249 (1997).
   PubMed Web of Science ®Google Scholar
• Isotani E, Suzuki R, Tomita K et al. Alterations in plasma concentrations of natriuretic peptides and antidiuretic hormone after subarachnoid hemorrhage. Stroke25(11), 2198–2203 (1994).
   PubMed Web of Science ®Google Scholar
• Adrogue HJ. Consequences of inadequate management of hyponatremia. Am. J. Nephrol.25(3), 240–249 (2005).
   PubMed Web of Science ®Google Scholar
• Goldsmith SR. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure. Am. J. Cardiol.95(9A), 14B–23B (2005).
   PubMed Web of Science ®Google Scholar
• Verbalis JG. Vasopressin V2 receptor antagonists. J. Mol. Endocrinol.29(1), 1–9 (2002).
   PubMed Web of Science ®Google Scholar
• Serradeil-Le Gal C. An overview of SR121463, a selective non-peptide vasopressin V(2) receptor antagonist. Cardiovasc. Drug Rev.19(3), 201–214 (2001).
   PubMedGoogle Scholar
• Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor. J. Pharmacol. Exp. Ther. DOI: 10.1124/jpet.105.095554 (2005).
   PubMedGoogle Scholar
• Segal A. Nephrogenic syndrome of inappropriate antidiuresis. N. Engl. J. Med.353(5), 529–530 (2005).
   PubMedGoogle Scholar
• Serradeil-Le Gal C, Wagnon J, Valette G et al. Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog. Brain Res.139, 197–210 (2002).
   PubMed Web of Science ®Google Scholar
• Palm C, Reimann D, Gross P. The role of V2 vasopressin antagonists in hyponatremia. Cardiovasc. Res.51(3), 403–408 (2001).
   PubMedGoogle Scholar
• Gheorghiade M, Niazi I, Ouyang J et al. (Tolvaptan Investigators). Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double blind, randomized trial. Circulation107(21), 2690–2696 (2003).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Teerlink JR, Mebazaa A. Pharmacology of new agents for acute heart failure syndromes. Am. J. Cardiol.96(6A), 68G–73G (2005).
   Web of Science ®Google Scholar
• Castello L, Pirisi M, Sainaghi PP et al. Hyponatremia in liver cirrhosis: pathophysiological principles of management. Dig. Liver Dis.37(2), 73–81 (2005).
   PubMedGoogle Scholar
• Ferguson JW, Therapondos G, Newby DE, Hayes PC. Therapeutic role of vasopressin receptor antagonism in patients with liver cirrhosis. Clin. Sci.105(1), 1–8 (2003).
   PubMed Web of Science ®Google Scholar
• Torres VE. Vasopressin antagonists in polycystic kidney disease. Kidney Int.68(5), 2405–2418 (2005).
   PubMed Web of Science ®Google Scholar
• Crook M. The investigation and management of severe hyponatremia. J. Clin. Pathol.55(12), 883 (2002).
   PubMedGoogle Scholar